Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results-Reference-Cited by-同舟云学术

Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results

Published:2020-07-14 Issue:1 Volume:19 Page:29-44
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Han Ru^ORCID,François Clément,Toumi Mondher

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40258-020-00600-w.pdf

Reference107 articles.

1. Han R, Zhou J. PIN11—comparison of clinical burden of HCV infection between Asia and Europe: an overview of systematic review, in ISPOR Asia Pacific 2018. Tokyo: Elsevier; 2018.

2. World Health Organization. Global Hepatitis report, 2017 [cited 30 Aug 2018]. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed 15 May 2018.

3. Han R, et al. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update. BMC Infect Dis. 2019;19(1):655.

4. Martin NK, et al. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention. Curr Opin HIV AIDS. 2015;10(5):374–80.

5. Han R, Zhou J. PIN19 - a cost comparison of treating chronic hepatitis c patients with sofosbuvir-based regimens. Value Health. 2018;21:S224.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Literature Review and Meta-Analysis of Primary Evidence Reporting Health-State Preference Values in Chronic Hepatitis B, C, and D;Value in Health;2024-06

2. Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations;PharmacoEconomics;2024-03-29

3. Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study;Medical Decision Making;2023-07-22

4. Health-related quality of life among people who inject drugs in Australia;Quality of Life Research;2023-06-23

5. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression;Health and Quality of Life Outcomes;2022-12-23